Steve O'Loughlin, Principal Financial Officer at Actinium Pharmaceuticals, Inc. (ATNM), bought 12,000 shares at $0.50 ($6K) on 2018-06-15, disclosed to the SEC on 2018-06-15.
Open-market purchase of $6k ATNM by Principal Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |